Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04765111
What this trial is testing

Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 53
Not applicableStudy completedNCT06093334
What this trial is testing

Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD

Who this might be right for
Acute Lymphoblastic LeukemiaHodgkin DiseaseAllogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 27
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Testing effectiveness (Phase 2)Ended earlyNCT02092909
What this trial is testing

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 31
Post-approval studies (Phase 4)Study completedNCT00526409
What this trial is testing

LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 40
Testing effectiveness (Phase 2)Study completedNCT00695409
What this trial is testing

Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07818499
What this trial is testing

BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 204
Testing effectiveness (Phase 2)Looking for participantsNCT07110844
What this trial is testing

Teclistamab-Daratumumab in AL Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Rajshekhar Chakraborty, MD 25
Not applicableLooking for participantsNCT06853834
What this trial is testing

Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis

Who this might be right for
Sarcoidosis LungPulmonary Sarcoidosis
Sanjay Gandhi Postgraduate Institute of Medical Sciences 150
Post-approval studies (Phase 4)UnknownNCT02992834
What this trial is testing

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Who this might be right for
Lymphoma, B Cell
jiangjingting 10
Not applicableUnknownNCT04640064
What this trial is testing

Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group

Who this might be right for
Type1diabetesChildhood ALL
Hospital General Puyo 500
Not applicableUnknownNCT01562509
What this trial is testing

PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care

Who this might be right for
Non-Hodgkin Lymphoma
Radboud University Medical Center 418
Very early researchEnded earlyNCT02640209
What this trial is testing

Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)

Who this might be right for
LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
University of Pennsylvania 20
Early research (Phase 1)Study completedNCT01580371
What this trial is testing

Safety and Pharmacokinetic Profile of CKD-581

Who this might be right for
LymphomaMultiple Myeloma
Chong Kun Dang Pharmaceutical 39
Early research (Phase 1)Study completedNCT01275209
What this trial is testing

Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Novartis Pharmaceuticals 1
Testing effectiveness (Phase 2)Ended earlyNCT03860844
What this trial is testing

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Sanofi 67
Not applicableActive Not RecruitingNCT04282811
What this trial is testing

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

Who this might be right for
Chronic Lymphocytic LeukemiaRelapse LeukemiaRefractory Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 321
Not applicableStudy completedNCT04014764
What this trial is testing

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Who this might be right for
Acute Myelogenous LeukemiaMultiple MyelomaMyelodysplastic Syndromes+4 more
Notable Labs 119
Early research (Phase 1)Ended earlyNCT05032599
What this trial is testing

Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia
Beijing Boren Hospital 19
Testing effectiveness (Phase 2)WithdrawnNCT04448834
What this trial is testing

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Dorothy Sipkins, MD, PhD
Next Page